Postbiotics—Bioactive Microbial Compounds as Health-Promoting Agents

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology".

Deadline for manuscript submissions: 15 September 2025 | Viewed by 841

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland
Interests: oxidative stress; bioactive food compounds; dietetics; neurodegeneration
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland
Interests: molecular basis of civilization diseases; microRNA; microbiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The human gut microbiome is emerging as an essential agent in the interaction between diet and metabolic health. Postbiotics, which are probiotic metabolites such as short-chain fatty acids (SCFAs), bile acids, vitamins, tryptophan, or indole derivatives, serve as key molecular mediators between the microbiota and the host. Postbiotics play an important role in maintaining a proper intestinal barrier and the condition of the entire gastrointestinal tract, but there are also a growing number of reports on the action of these bioactive compounds in various other tissues of the body. The mechanism and effects of postbiotics on human health are not yet fully understood. More and more studies demonstrate their effect on reducing inflammation and oxidative stress, eliminating the presence of harmful pathogens or stimulating the human immune system.

Probiotic supplementation has many health benefits, but is not without drawbacks such as quality fluctuations, short shelf life, heterogeneous effects, and incompatibility with immunocompromised people. Postbiotics, meanwhile, are safer and more stable, easier to store, and are associated with a lower risk of antimicrobial resistance. Postbiotics are therefore becoming a new target for research into harnessing their health-promoting potential.

This Special Issue invites high-quality original research papers, as well as comprehensive reviews focusing on the roles of postbiotics in supporting human health and preventing various diseases.

Dr. Katarzyna Oszajca
Prof. Dr. Janusz Szemraj
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • postbiotics
  • prebiotics
  • microbiota-derived metabolites
  • postbiotic supplementation
  • postbiotics and health benefits
  • dysbiosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 7855 KiB  
Article
Novel Acylated Naringin Enhances Propionate Release and Stimulates the Growth of Flavanone-Metabolizing Bacteria in an In Vitro Batch Fermentation Model
by Blanca Elizabeth Ruiz-Álvarez, José Daniel Padilla-de la Rosa, Marisela González Avila, Georgina Sandoval and Yves Desjardins
Life 2025, 15(6), 967; https://doi.org/10.3390/life15060967 - 17 Jun 2025
Viewed by 639
Abstract
The increasing prevalence of non-communicable diseases (NCDs) is strongly associated with gut microbiota (GM) imbalances and reduced short-chain fatty acid (SCFA) production, primarily driven by poor diet and microbial dysbiosis. Since SCFAs are crucial for gut health, immune regulation, and inflammation control, restoring [...] Read more.
The increasing prevalence of non-communicable diseases (NCDs) is strongly associated with gut microbiota (GM) imbalances and reduced short-chain fatty acid (SCFA) production, primarily driven by poor diet and microbial dysbiosis. Since SCFAs are crucial for gut health, immune regulation, and inflammation control, restoring their levels is a key therapeutic target. SCFA-acylated naringin derivatives offer a novel approach by enhancing SCFA delivery and modulating GM composition. In this study, we investigated the effects of naringin acetate and naringin propionate on SCFA production using a 24 h short-term in vitro batch fecal fermentation model with microbiota from two donors. Naringin propionate and naringin plus free propionate significantly increased propionate levels by 0.74 mM and 0.75 mM, respectively (p < 0.0001), while naringin acetate induced a smaller increase of 0.26 mM. Donor-specific reflected differences in microbial communities, yet SCFA enhancement was observed across samples. Additionally, naringin treatments stimulated the growth of beneficial polyphenol-metabolizing bacteria, including Bacteroides, Streptococcus, and Eubacterium siraeum. The strong effect of naringin propionate suggests a sustained SCFA release mediated by microbial enzymes. These preliminary results highlight the potential of SCFA-acylated flavonoids as functional dietary components to increase SCFA bioavailability and support gut health, particularly from citrus-derived co-products. Full article
Show Figures

Figure 1

Back to TopTop